Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer: Enhancing clinical relevance.
메타분석
1/5 보강
Gastric cancer (GC) is a leading cause of cancer-related deaths, highlighting the need for reliable prognostic biomarkers to guide treatment.
- 연구 설계 systematic review
APA
Sundararaju U, Rajakumar HK (2025). Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer: Enhancing clinical relevance.. World journal of gastrointestinal oncology, 17(4), 103128. https://doi.org/10.4251/wjgo.v17.i4.103128
MLA
Sundararaju U, et al.. "Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer: Enhancing clinical relevance.." World journal of gastrointestinal oncology, vol. 17, no. 4, 2025, pp. 103128.
PMID
40235867 ↗
Abstract 한글 요약
Gastric cancer (GC) is a leading cause of cancer-related deaths, highlighting the need for reliable prognostic biomarkers to guide treatment. Wei 's systematic review and meta-analysis evaluates the neutrophil-to-lymphocyte ratio (NLR) as a potential biomarker for GC patients undergoing neoadjuvant chemotherapy. NLR is a simple and cost-effective measure of systemic inflammation that shows promise in predicting treatment response and survival outcomes, including overall survival and progression-free survival. However, variations in NLR thresholds and timing of measurements affect its accuracy and clinical utility. Moreover, the studies reviewed primarily involved Asian populations, which may limit the generalizability of the findings. To improve NLR's clinical relevance, future research should focus on standardizing NLR thresholds, refining measurement timing, and incorporating additional inflammatory markers like platelet-to-lymphocyte ratio and Glasgow prognostic score. Addressing confounders and including diverse patient populations will help improve NLR's reliability as a prognostic marker for GC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Association of preoperative frailty and prognostic nutritional index with postoperative delirium in elderly gastric cancer patients: A single-center observational study.
- Assessment of Early Breast Cancer Response to Chemotherapy with Ultrasound Radiomics.
- Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer).
- Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.